Sarepta Therapeutics (SRPT) Q2 Earnings and Revenues Surpass Estimates
Yahoo Finance · Aug 6, 2026 · Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of +10.35% and +12.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Not investment advice. Cached headline, not a full reprint.